Genetic variations may be one of the important factors that influence breast cancer survivors' responses to the inflammatory processes and vulnerability to lymphedema.
IL1-ars17561 was marginally associated with symptom count phenotype of ≥8 symptoms.
IL-4 rs2070874 was significantly associated with phenotype of impaired limb mobility and fluid accumulation.
Phenotype of fluid accumulation was significantly associated with IL6 rs1800795, IL4 rs2243250 and IL4 rs2070874.
Phenotype of discomfort was significantly associated with VEGF-C rs3775203 and IL13 rs1800925.